Your browser doesn't support javascript.
loading
A double-blind, placebo-controlled trial of the efficacy and safety of two doses of azelastine hydrochloride in perennial allergic rhinitis.
Bousquet, Jean; Klimek, Ludger; Kuhl, Hans-Christian; Nguyen, Duc Tung; Ramalingam, Rajesh Kumar; Canonica, G W; Berger, William E.
Afiliación
  • Bousquet J; Institute of Allergology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Klimek L; Allergology and Immunology, Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Berlin, Germany.
  • Kuhl HC; Center for Rhinology and Allergology, Wiesbaden, Hessen, Germany.
  • Nguyen DT; Biometrics, Meda Pharma GmbH & Co KG (A Viatris Company), Bad-Homburg, Germany.
  • Ramalingam RK; Global Clinical Sciences, MEDA Pharma GmbH & Co KG (A Viatris Company), Bad Homburg, Germany.
  • Canonica GW; Mylan Pharmaceuticals Private Limited (Now Viatris), Bengaluru, India.
  • Berger WE; Department of Biomedical Sciences, Humanitas University, Milan, Italy.
Front Allergy ; 4: 1244012, 2023.
Article en En | MEDLINE | ID: mdl-37920410
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Front Allergy Año: 2023 Tipo del documento: Article País de afiliación: Alemania
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Front Allergy Año: 2023 Tipo del documento: Article País de afiliación: Alemania